DIABETIC KETOACIDOSIS ASSOCIATED WITH EMPAGLIFLOZIN THERAPY : MECHANISMS, RISC FACTORS AND CLINICAL IMPLICATIONS. International journal of artificial intelligence, [S. l.], v. 5, n. 09, p. 221–223, 2025. Disponível em: https://www.academicpublishers.org/journals/index.php/ijai/article/view/6299.. Acesso em: 17 sep. 2025.